This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Famotidine is a medicine used to treat certain stomach and digestive problems such as heartburn, acid reflux, and peptic ulcers. It belongs to a class of drugs called histamine-2 blockers, which work by reducing the amount of acid produced in the stomach. Famotidine is available both over-the-counter (OTC) and by prescription. Famotidine is most commonly used to treat heartburn, which is caused by acid reflux. It works by reducing the amount of acid produced in the stomach, which reduces the irritation and burning sensation associated with heartburn. Famotidine can also be used to help prevent stomach ulcers by reducing the amount of acid produced in the stomach. It is sometimes used as part of a treatment plan for people who have had a history of ulcers, or who are at risk for developing them. Famotidine is a relatively safe medicine, with few side effects. The most common side effects include headache, dizziness, and constipation. It is important to take famotidine exactly as prescribed by your doctor. Overdose of famotidine can cause serious side effects and should be avoided. Famotidine is an effective and safe way to treat heartburn and prevent stomach ulcers. It is widely available both over-the-counter and by prescription, so it is easy to get. If you experience any side effects while taking famotidine, contact your doctor right away.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States